In AD patients and animal models, the mRNA levels of Nrf2 were significantly reduced, and Nrf2 deficiency accelerated BACE1 expression and Aβ production (Bahn et al., 2019). This evidence concerns the gene NFE2L2 and Alzheimer disease.